The effect of specific immunotherapy on the expression of costimulatory molecules in late phase reaction of the skin in allergic patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical and Experimental Allergy

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2222.2004.02120.xPMID 15663560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of cytokine production by mononuclear cells in allergic inflammation. The effects of allergen exposure and anti-inflammatory agents

  2003cited by this paper
• Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

  2003cited by this paper
• Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1

  2002cited by this paper
• Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

  2002cited by this paper
• The safety and efficacy of subcutaneous birch pollen immunotherapy – a one‐year, randomised, double‐blind, placebo‐controlled study

  2002cited by this paper
• Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy.

  2002cited by this paper
• Expression of costimulatory CD80/CD86‐CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis

  2001cited by this paper
• Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium

  2001cited by this paper
• Interleukin‐10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy

  2001cited by this paper
• [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies].

  2001cited by this paper
• A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding

  2000cited by this paper
• Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

  2000cited by this paper
• IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway

  2000cited by this paper
• Allergen immunotherapy: does it work and, if so, how and for how long?

  2000cited by this paper
• Antigen-presenting cells. Experimental and clinical studies of dendritic cells.

  2000cited by this paper
• Expression of Cd28 and Cd86 by Human Eosinophils and Role in the Secretion of Type 1 Cytokines (Interleukin 2 and Interferon γ)

  1999cited by this paper
• Immunohistochemical investigation of the cellular infiltrates at the sites of allergoid‐induced late‐phase cutaneous reactions associated with pollen allergen‐specific immunotherapy

  1999cited by this paper
• Role of interleukin 10 in specific immunotherapy.

  1998cited by this paper
• Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

  1997cited by this paper
• Immunohistochemical analysis of late local skin reactions during rush venom immunotherapy.

  1997cited by this paper
• Requirement of CD80 and CD86 Molecules for Antigen Presentation by Eosinophils

  1996cited by this paper
• Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation

  1996cited by this paper
• The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen.

  1994cited by this paper
• Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases.

  1994cited by this paper
• Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes

  1994cited by this paper
• B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

  1994cited by this paper
• Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

  1993cited by this paper
• IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

  1993cited by this paper
• Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

  1991cited by this paper
• Inhibition of endogenous peroxidase for the immunocytochemical demonstration of intermediate filament proteins (IFP).

  1989cited by this paper
• The pattern of human late-phase skin reactions to extracts of aeroallergens.

  1988cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper

• CD86 immunohistochemical staining for the detection of Talaromyces marneffei in lesions

  2025cites this paper
• Allergen immunotherapy and tolerance.

  2013cites this paper
• Series : Immunotherapy and Tolerance — Cutting Edge Allergen Immunotherapy and Tolerance

  2013cites this paper
• Allergen Immunotherapy and

  2013cites this paper
• Role of Toll-like receptors in airway inflammation

  2009cites this paper
• Immunotherapy for Inhalant Allergens

  2009cites this paper
• Immunomodulation of allergic immune response during specific immunotherapy

  2009influential citation
• Nature of Regulatory T Cells in the Context of Allergic Disease

  2008cites this paper
• A follow‐up study of immunotherapy‐treated birch‐allergic patients: effect on the expression of chemokines in the nasal mucosa

  2008cites this paper
• Allergen immunotherapy: a practice parameter third update.

  2007cites this paper
• Author Index

  2004cites this paper